Clincosm LogoSign in Get a demo

primary peritoneal carcinoma

Showing 26 - 50 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Epithelial Ovarian, Recurrent Epithelial Ovarian, Fallopian Tube Trial in United States (Enzalutamide)

Completed
  • Advanced Epithelial Ovarian
  • +3 more
  • Basking Ridge, New Jersey
  • +5 more
Mar 4, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (SL-172154)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Duarte, California
  • +8 more
Feb 23, 2022

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Hepato-celiac lymphadenectomy)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Hepato-celiac lymphadenectomy
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Feb 9, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Shanghai (Primary debulking surgery, Neoadjuvant

Not yet recruiting
  • Ovarian Cancer
  • +2 more
  • Primary debulking surgery
  • +2 more
  • Shanghai, China
    Zhongshan Hospital, Fudan University
Jan 17, 2022

Ovarian Cancer, Ovarian Carcinoma, Ovary Cancer Trial in Spain, United States (STRO-002)

Recruiting
  • Ovarian Cancer
  • +6 more
  • Tucson, Arizona
  • +25 more
Dec 20, 2021

Complications in Older Gynecologic Cancer Undergoing Surgery

Completed
  • Endometrial Serous Adenocarcinoma
  • +9 more
  • Comprehensive Geriatric Assessment
  • Questionnaire Administration
  • Birmingham, Alabama
  • +392 more
Nov 23, 2021

Fallopian Tube Carcinoma, Fallopian Tube Carcinosarcoma, Fallopian Tube Clear Cell Adenocarcinoma Trial in United States

Completed
  • Fallopian Tube Carcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +22 more
Oct 19, 2021

Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in China, Korea, Republic of (Upfront

Recruiting
  • Epithelial Ovarian Cancer
  • +2 more
  • Upfront cytoreductive surgery
  • Interval debulking surgery
  • Guangzhou, Guangdong, China
  • +7 more
Oct 8, 2021

Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma, Stage I Ovarian Cancer Trial in Buffalo (procedure, drug, other)

Completed
  • Fallopian Tube Carcinoma
  • +14 more
  • Diagnostic Microscopy
  • +2 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Oct 5, 2021

Epithelial Ovarian Cancer, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial (AVB-S6-500, Paclitaxel, Carboplatin)

Withdrawn
  • Epithelial Ovarian Cancer
  • +2 more
  • (no location specified)
Sep 23, 2021

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Germany, Italy (Niraparib)

Recruiting
  • Ovarian Cancer
  • +2 more
  • Berlin, Germany
  • +11 more
Sep 15, 2021

Cytomegalovirus and Inflammation on Patient Symptoms and

Recruiting
  • Ovarian Cancer
  • +2 more
    • Minneapolis, Minnesota
      University of Minnesota
    Sep 7, 2021

    Peritoneal Mesothelioma, Fallopian Tube Adenocarcinoma, Adenocarcinoma of the Ovary Trial in United States (MCY-M11,

    Terminated
    • Peritoneal Mesothelioma
    • +3 more
    • Rockville, Maryland
    • +3 more
    Aug 30, 2021

    Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

    Completed
    • Fallopian Tube Carcinoma
    • +2 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2021

    Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in United States (Rucaparib, Nivolumab)

    Terminated
    Has Results
    • Epithelial Ovarian Cancer
    • +4 more
    • Clovis, California
    • +4 more
    May 19, 2021

    Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Oklahoma City (Paclitaxel, Cisplatin IP)

    Terminated
    Has Results
    • Ovarian Cancer
    • +3 more
    • Paclitaxel, Cisplatin IP
    • Oklahoma City, Oklahoma
      University of Oklahoma Health Sciences Center
    Apr 28, 2021

    Epithelial Ovarian Carcinoma, Fallopian Tube Carcinoma, Primary Peritoneal Carcinoma Trial in Beijing (DCVAC/OvCa, Placebo)

    Recruiting
    • Epithelial Ovarian Carcinoma
    • +2 more
    • DCVAC/OvCa
    • Placebo
    • Beijing, Beijing, China
      Peking University Third Hospital
    Apr 30, 2021

    Primary Peritoneal Carcinoma Trial in Baltimore (Tremelimumab, Olaparib)

    Terminated
    • Primary Peritoneal Carcinoma
    • Baltimore, Maryland
      Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
    Apr 9, 2021

    Cancer Diagnosis and Treatment on Everyday Life

    Active, not recruiting
    • Breast Cancer Female
    • +17 more
      • Aberystwyth, United Kingdom
      • +110 more
      Mar 16, 2021

      Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Worldwide (Paclitaxel(intravenous) +

      Active, not recruiting
      • Epithelial Ovarian Cancer
      • +2 more
      • Paclitaxel(intravenous) + Carboplatin(intravenous)
      • Paclitaxel(intravenous) + Carboplatin(intraperitoneal)
      • Pittsburgh, Pennsylvania
      • +61 more
      Mar 15, 2021

      Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Worldwide (Ganetespib, Niraparib, Carboplatin)

      Unknown status
      • Ovarian Cancer
      • +2 more
      • Innsbruck, Austria
      • +12 more
      Jan 26, 2021

      Breast Cancer, Ovarian Cancer, Fallopian Tube Cancer Trial in Dallas (Vigil, Durvalumab)

      Completed
      • Breast Cancer
      • +6 more
      • Dallas, Texas
        Mary Crowley Cancer Research Center
      Jan 26, 2021

      Primary Peritoneal Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma Trial in Lexington (neoadjuvant chemo)

      Completed
      Has Results
      • Primary Peritoneal Carcinoma
      • +2 more
      • neoadjuvant chemotherapy
      • Lexington, Kentucky
        University of Kentucky Markey Cancer Center
      Nov 17, 2020

      Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

      Completed
      Has Results
      • Borderline Ovarian Serous Tumor
      • +5 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Los Angeles, California
      • +48 more
      Dec 2, 2020

      Recurrent Epithelial Cancer of Ovary, Primary Peritoneal Carcinoma, Fallopian Tube Cancer Trial in Dallas (Avelumab)

      Terminated
      Has Results
      • Recurrent Epithelial Cancer of Ovary
      • +2 more
      • Dallas, Texas
        University of Texas Southwestern Medical Center
      Oct 19, 2020